Aspira Pathlab & Diagnostics Ltd
₹114.95▼ -6.00 (-4.96%)
ASPIRA·BSE·Healthcare Services
Market Cap
118.32 Cr
PE Ratio
2299.00
Volume
212
Day High - Low
126.00 - 114.95
52W High-Low
149.99 - 49.00
₹114.95▼ -6.00 (-4.96%)
Market Cap118.32 Cr
PE Ratio2299.00
Volume212
Day High - Low126.00 - 114.95
52W High-Low149.99 - 49.00
Aspira Pathlab & Diagnostics Ltd (ASPIRA): company summary
The company's revenue grew 13.5% annually, reaching ₹25 crore, but net profit fell 97.5% to ₹0 crore.
Aspira Pathlab & Diagnostics Ltd (ASPIRA) is a micro-cap Healthcare Services company valued at ₹118 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Aspira Pathlab & Diagnostics Ltd last traded at ₹114.95, down 4.96% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit loss of ₹0 crore for the latest quarter, reversing a previous profit of ₹0 crore. Promoter holding increased by 28.19 percentage points to 46.58% as of 2026-06-30.
- Financial performance
- The company's revenue grew 13.5% annually, reaching ₹25 crore, but net profit fell 97.5% to ₹0 crore. The latest quarter saw revenue rise 17.5% year-over-year to ₹6 crore, but net profit swung from a profit of ₹0 crore to a loss of ₹0 crore.
- Valuation multiples
- The stock trades at 2299.0 times earnings, 7.96 times book value.
- Things to watch
- The company reported a net profit of ₹0 crore for the latest quarter, reversing a previous profit of ₹0 crore. Net profit margin fell 9.0 percentage points to 0.2%. The stock is 19.4% below its 52-week high.
- Where it stands
- The company's revenue grew 13.5% annually, but net profit fell to ₹0 crore. The latest quarter saw revenue rise 17.5% year-over-year, but net profit swung to a loss. The stock is 19.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.2/10
Poor
Fair Value
Sign in to see
ROE
0.42%
Weak
P/E
2299.00x
Expensive
Debt / Equity
0.11
Low
Industry
Healthcare Services
Healthcare Service Provider
Overall View
Poor
Price performance
Day₹114.95
₹126.00
52W₹49.00
₹149.99
DocStoX take
Supported by momentum (7.2) and risk (6.9), but held back by valuation (0.0).
DocStoX score
Low confidence3.2
/10
Poor
Quality
Weak
ROE 0.4%
Valuation
Expensive
P/E 200.0×
Growth
Flat
Revenue +10.4% 5Y CAGR
Risk
Moderate
D/E 0.11
Momentum
Firm
65% of 52-week range
At a glance
Market Cap
₹118 Cr
52W High / Low
₹150 / ₹49
Dividend Yield
0.00%
Promoter Holding
46.65%
EPS (TTM)
₹0.05
Book Value
₹11.88
Key highlights
- Low leverage — D/E 0.11
- Profit shrinking 49% a year
- Loss-making in some of the last 5 years
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare Services stocks · Healthcare Service Provider
Explore Aspira Pathlab & Diagnostics Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Aspira Pathlab & Diagnostics Ltd peers in Healthcare Services
Other Healthcare Services stocks on the NSE & BSE. See the full Healthcare Services sector list.
Related tools & concepts
Value Aspira Pathlab & Diagnostics Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing